Hikma Pharmaceuticals

MedCity Influencers

Baxter selling generic injectables business to U.K. firm

Baxter International Inc. (NYSE:BAX) is planning to offload its U.S.-based generic injectables business to British drug firm Hikma Pharmaceuticals PLC (LSE:HIK). The deal is worth about $112 million to the Deerfield, Illinois-based company, according to a statement. The agreement is comprised of Hikma acquisition of Baxter’s injectable products in vials and ampules, which are marketed […]